ocrelizumab
Roche
[]
1 in 2 patients with ms haven t discussed disability progression with their hcp.* start the conversation when you get back from #aanam. please see full prescribing information at intended for us healthcare professionals only. *see video for references.
Learn more about OCREVUS. Read Full Important Safety Information at https://t.co/wZz9k9NtyQ and Prescribing Information at https://t.co/BCJnTyQhQj.